A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said on Wednesday its net profit jumped 21 per cent in 2024 to 100 billion Danish ...

Sales of weight loss drug Wegovy more than doubled in the final three months of 2024, as manufacturer Novo Nordisk predicted growth will slow this year. The Danish pharmaceutical company has ...

Danish pharmaceutical behemoth Novo Nordisk on Wednesday reported better-than-expected net profit in the fourth quarter, amid soaring demand for its Wegovy obesity drugs. Net profit for the fourth ...

LONDON/COPENHAGEN (Reuters) -Obesity drug maker Novo Nordisk (NYSE:NVO) forecast slower growth this year after Wegovy sales more than doubled in the fourth quarter, with analysts and investors ...